Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 40 of about 56 companies and 29 funds for Christopher D. Scott
Company Exchange Symbol Last price Quote change Market cap
Barnes & Noble, Inc. NYSE BKS 12.78 +0.14 (1.11%) 954.46M
Barnes & Noble, Inc. is a bookseller. The Company is a content and commerce company, which provides access to trade books and other content across its ...
Executive:
Christopher Grady-Troia
Cascadian Therapeutics Inc (USA) NASDAQ CASC 1.14 0.00 (0.00%) 148.16M
Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company. The Company focuses on the development of ...
Executive:
Christopher S. Henney Ph.D.
Pengrowth Energy Corp (USA) NYSE PGH 1.53 -0.02 (-1.29%) 827.62M
Pengrowth Energy Corporation is engaged in the production, development, exploration and acquisition of oil and natural gas assets. The Company is focused on ...
Executive:
Christopher G. Webster
Expedia Inc NASDAQ EXPE 117.20 +0.62 (0.53%) 17.53B
Expedia, Inc. is an online travel company. The Company makes travel products and services available, on a standalone and package basis, provided by various ...
Executive:
Christopher W. Shean
SPX Corporation NYSE SPXC 15.44 -0.20 (-1.25%) 641.01M
SPX Corporation is a diversified, global supplier of infrastructure equipment. The Company operates through three segments: heating, ventilation and air ...
Executive:
Christopher J. Kearney
Zumiez Inc. NASDAQ ZUMZ 16.17 +0.01 (0.06%) 407.01M
Zumiez Inc. is a specialty retailer of apparel, footwear, accessories and hardgoods for men and women. The Company operates under the names Zumiez and Blue ...
Executive:
Christopher C. Work
Karyopharm Therapeutics Inc NASDAQ KPTI 7.03 -0.11 (-1.54%) 248.91M
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs ...
Executive:
Christopher B. Primiano
Nektar Therapeutics NASDAQ NKTR 15.20 -0.19 (-1.23%) 2.05B
Nektar Therapeutics is a biopharmaceutical company. The Company is engaged in the development of a pipeline of drug candidates that utilize its PEGylation ...
Executive:
Christopher A. Kuebler
Aqua America Inc NYSE WTR 34.56 +0.47 (1.38%) 6.21B
Aqua America, Inc. is a holding company. The Company, through its subsidiaries, provides water or wastewater services in Pennsylvania, New Jersey, ...
Executive:
Christopher H. Franklin
Starz NASDAQ STRZA 30.74 +0.04 (0.13%) 3.03B
Starz is an integrated media and entertainment company. The Company provides subscription video programming in the United States to cable operators, ...
Executive:
Christopher P. Albrecht
Rayonier Inc. NYSE RYN 27.12 +0.16 (0.59%) 3.35B
Rayonier Inc. is a timberland real estate investment trust (REIT) with assets located in timber growing regions in the United States and New Zealand.
Executive:
Christopher T. Corr
Descartes Systems Group Inc (USA) NASDAQ DSGX 19.61 -0.04 (-0.20%) 1.49B
The Descartes Systems Group Inc. (Descartes) is a global provider of on-demand, cloud-based software-as-a-service (SaaS) solutions.
Executive:
Christopher Hewat LL.B.
DuPont Fabros Technology, Inc. NYSE DFT 47.30 +1.00 (2.16%) 3.64B
DuPont Fabros Technology, Inc. (DFT) is a real estate investment trust (REIT). The Company is a self-administered and self-managed company that owns, ...
Executive:
Christopher P. Eldredge
Clear Channel Outdoor Holdings, Inc. NYSE CCO 6.97 +0.06 (0.87%) 2.54B
Clear Channel Outdoor Holdings, Inc. is an outdoor advertising company. The Company owns and operates billboards, street furniture displays, ...
Executive:
Christopher William Eccleshare
Emera Inc TSE EMA 49.52 +0.21 (0.43%) 7.34B
Emera Incorporated is an energy and services company that invests in electricity generation, transmission and distribution, as well as gas transmission and ...
Executive:
Christopher G. Huskilson
Pengrowth Energy Corp TSE PGF 2.01 -0.02 (-0.99%) 1.08B
Pengrowth Energy Corporation is engaged in the production, development, exploration and acquisition of oil and natural gas assets. The Company is focused on ...
Executive:
Christopher G. Webster
Agios Pharmaceuticals Inc NASDAQ AGIO 42.23 -0.74 (-1.72%) 1.57B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of orally available small molecule ...
Executive:
Christopher Bowden MD
Telephone & Data Systems, Inc. NYSE TDS 31.75 +0.70 (2.25%) 3.54B
Telephone and Data Systems, Inc. is a diversified telecommunications company. The Company conducts its Wireless operations through its subsidiary, ...
Executive:
Christopher D. O'Leary
Piper Jaffray Companies NYSE PJC 41.20 -0.25 (-0.60%) 659.08M
Piper Jaffray Companies is an investment bank and asset management company, which serves the needs of corporations, private equity groups, public entities, ...
Executive:
Christopher D. Crawshaw
Celanese Corporation NYSE CE 70.24 +0.41 (0.59%) 10.42B
Celanese Corporation (Celanese) is a technology and specialty materials company. The Company operates through four segments: Advanced Engineered Materials, ...
Executive:
Christopher W. Jensen CPA
Show all 56 companies »
Mutual Fund Symbol Nav Nav change
Strategic Advisers´┐Ż Small-Mid Cap Fund FSCFX 12.85 +0.10 (0.78%)
The investment seeks capital appreciation. The fund invests at least 80% of assets in securities of small and mid cap companies (which, for purposes of this ...
Executive:
Christopher D.
RS Small Cap Growth Fund Class A RSEGX 61.13 +0.74 (1.23%)
The investment seeks long-term capital growth. The fund normally invests at least 80% of its net assets in small-capitalization companies.
Executive:
Christopher W. Clark
AAM/Bahl & Gaynor Income Growth Fund Class A AFNAX 14.36 +0.07 (0.49%)
The investment seeks primarily current and growing income and secondarily long- term capital appreciation. Under normal market conditions, the fund invests ...
Executive:
Christopher M. Rowane
RS Select Growth Fund Class A RSDGX 45.02 +0.35 (0.78%)
The investment seeks long-term capital growth. The fund typically invests in a portfolio of small- and mid-capitalization growth-oriented companies.
Executive:
Christopher W. Clark
AAM/Bahl & Gaynor Income Growth Fund Class I AFNIX 14.39 +0.07 (0.49%)
The investment seeks primarily current and growing income and secondarily long- term capital appreciation. Under normal market conditions, the fund invests ...
Executive:
Christopher M. Rowane
RS Small Cap Equity Fund Class A GPSCX 13.42 +0.16 (1.21%)
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets in equity securities of small-capitalization ...
Executive:
Christopher W. Clark
RS Growth Fund Class A RSGRX 17.89 +0.07 (0.39%)
The investment seeks long-term capital growth. The fund invests principally in equity securities of companies considered by the fund's investment team (at ...
Executive:
Christopher W. Clark
RS Mid Cap Growth Fund Class A RSMOX 21.38 +0.13 (0.61%)
The investment seeks long-term capital growth. The fund invests principally in equity securities. It normally invests at least 80% of its net assets in ...
Executive:
Christopher W. Clark
AAM/Bahl & Gaynor Income Growth Fund Class C AFYCX 14.25 +0.06 (0.42%)
The investment seeks primarily current and growing income and secondarily long- term capital appreciation. Under normal market conditions, the fund invests ...
Executive:
Christopher M. Rowane
RS Small Cap Growth Fund Class Y RSYEX 62.72 +0.75 (1.21%)
The investment seeks long-term capital growth. The fund normally invests at least 80% of its net assets in small-capitalization companies.
Executive:
Christopher W. Clark
RS Select Growth Fund Class Y RSSYX 46.04 +0.36 (0.79%)
The investment seeks long-term capital growth. The fund typically invests in a portfolio of small- and mid-capitalization growth-oriented companies.
Executive:
Christopher W. Clark
RS Select Growth Fund Class C RSGFX 41.15 +0.32 (0.78%)
The investment seeks long-term capital growth. The fund typically invests in a portfolio of small- and mid-capitalization growth-oriented companies.
Executive:
Christopher W. Clark
RS Small Cap Equity Fund Class Y RSCYX 13.59 +0.16 (1.19%)
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets in equity securities of small-capitalization ...
Executive:
Christopher W. Clark
RS Select Growth Fund Class K RSDKX 41.18 +0.32 (0.78%)
The investment seeks long-term capital growth. The fund typically invests in a portfolio of small- and mid-capitalization growth-oriented companies.
Executive:
Christopher W. Clark
VALIC Company I Small Cap Aggressive Growth Fund VSAGX 10.55 +0.12 (1.15%)
The investment seeks capital growth. The fund normally invests at least 80% of its net assets in small-cap companies. The fund's managers consider a company ...
Executive:
Christopher W. Clark
RS Small Cap Growth Fund Class K RSEKX 57.74 +0.69 (1.21%)
The investment seeks long-term capital growth. The fund normally invests at least 80% of its net assets in small-capitalization companies.
Executive:
Christopher W. Clark
RS Small Cap Growth Fund Class C REGWX 55.39 +0.67 (1.22%)
The investment seeks long-term capital growth. The fund normally invests at least 80% of its net assets in small-capitalization companies.
Executive:
Christopher W. Clark
RS Growth Fund Class Y RGRYX 18.31 +0.08 (0.44%)
The investment seeks long-term capital growth. The fund invests principally in equity securities of companies considered by the fund's investment team (at ...
Executive:
Christopher W. Clark
RS Mid Cap Growth Fund Class Y RMOYX 21.94 +0.14 (0.64%)
The investment seeks long-term capital growth. The fund invests principally in equity securities. It normally invests at least 80% of its net assets in ...
Executive:
Christopher W. Clark
RS Mid Cap Growth Fund Class K RSMKX 20.19 +0.12 (0.60%)
The investment seeks long-term capital growth. The fund invests principally in equity securities. It normally invests at least 80% of its net assets in ...
Executive:
Christopher W. Clark
Show all 29 funds »